These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36916218)
1. Singh P; Patro S; Deep A; Mohapatra SK Trop Doct; 2023 Apr; 53(2):303-304. PubMed ID: 36916218 [TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcomes of non-cystic fibrosis patients with Burkholderia cepacia complex bacteremia at a medical center in Taiwan. Chang TH; Chuang YC; Wang JT; Sheng WH J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1301-1309. PubMed ID: 34674957 [TBL] [Abstract][Full Text] [Related]
3. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Horsley A; Jones AM Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Horsley A; Jones AM; Lord R Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009529. PubMed ID: 26789750 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Lord R; Jones AM; Horsley A Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009529. PubMed ID: 32239690 [TBL] [Abstract][Full Text] [Related]
6. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis. St Denis M; Ramotar K; Vandemheen K; Tullis E; Ferris W; Chan F; Lee C; Slinger R; Aaron SD Chest; 2007 Apr; 131(4):1188-96. PubMed ID: 17426227 [TBL] [Abstract][Full Text] [Related]
7. Management of Cepacia syndrome in an immunocompetent non-cystic fibrosis adult patient. Ottu Para NK; Vemuri S; Koshy G; Ibrahim D; Oomen S; Reddappa SV; Nadaf MS; Irfan RM; Wyon N; Ahmed MZ; Sundaram S Int J Infect Dis; 2022 Sep; 122():550-552. PubMed ID: 35811086 [TBL] [Abstract][Full Text] [Related]
8. Burkholderia cepacia genomovar III and Burkholderia vietnamiensis double infection in a cystic fibrosis child. Magalhães M; de Britto MC; Vandamme P J Cyst Fibros; 2002 Dec; 1(4):292-4. PubMed ID: 15463830 [TBL] [Abstract][Full Text] [Related]
9. A case of pan-resistant Burkholderia cepacia complex bacteremic pneumonia, after lung transplantation treated with a targeted combination therapy. Cantón-Bulnes ML; Hurtado Martínez Á; López-Cerero L; Arenzana Seisdedos Á; Merino-Bohorquez V; Garnacho-Montero J Transpl Infect Dis; 2019 Apr; 21(2):e13034. PubMed ID: 30548546 [TBL] [Abstract][Full Text] [Related]
10. Successful ceftazidime-avibactam treatment of post-surgery Burkholderia multivorans genomovar II bacteremia and brain abscesses in a young lung transplanted woman with cystic fibrosis. Daccò V; Claut L; Piconi S; Castellazzi L; Garbarino F; Teri A; Colombo C Transpl Infect Dis; 2019 Jun; 21(3):e13082. PubMed ID: 30892778 [TBL] [Abstract][Full Text] [Related]
11. Burkholderia cepacia complex infection in adult patients with cystic fibrosis--is early eradication possible? Etherington C; Peckham DG; Conway SP; Denton M J Cyst Fibros; 2003 Dec; 2(4):220-1. PubMed ID: 15463878 [No Abstract] [Full Text] [Related]
12. Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids. Kazachkov M; Lager J; LiPuma J; Barker PM Pediatr Pulmonol; 2001 Oct; 32(4):338-40. PubMed ID: 11568995 [TBL] [Abstract][Full Text] [Related]
13. Clinical and microbiological profile of chronic Burkholderia cepacia complex infections in a cystic fibrosis reference hospital in Brazil. da Costa Capizzani CP; Caçador NC; Torres LAGMM; Tonani L; Vandamme P; da Costa Darini AL Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2263-2271. PubMed ID: 28840370 [TBL] [Abstract][Full Text] [Related]
14. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis. Kitt H; Lenney W; Gilchrist FJ BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049 [TBL] [Abstract][Full Text] [Related]
15. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas. Jones AM; Dodd ME; Webb AK Eur Respir J; 2001 Feb; 17(2):295-301. PubMed ID: 11334134 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015. Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510 [TBL] [Abstract][Full Text] [Related]
17. Ceftazidime plasma concentration in a patient with cystic fibrosis treated with ceftazidime/avibactam plus trimethoprim/sulfametoxazole for Saffioti C; Barco S; Cangemi G; Mesini A; Casciaro R; Cresta F; Castellani C; Bandettini R; Morelli P; Castagnola E J Chemother; 2019; 31(7-8):436-438. PubMed ID: 31583970 [No Abstract] [Full Text] [Related]
18. Activity of Aerosolized Levofloxacin against Burkholderia cepacia in a Mouse Model of Chronic Lung Infection. Sabet M; Griffith DC Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712215 [No Abstract] [Full Text] [Related]
19. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients. Ratjen A; Yau Y; Wettlaufer J; Matukas L; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V Antimicrob Agents Chemother; 2015 Jan; 59(1):711-3. PubMed ID: 25348526 [TBL] [Abstract][Full Text] [Related]